Hematological manifestations of nephropathic cystinosis

Acta Haematologica

Volumn 119, Issue 3, 2008, Pages 169-172

  Emadi, Ashkan ^a   Burns, Kathleen H ^b   Confer, Bradley ^c   Borowitz, Michael J ^b   Streiff, Michael B ^b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LAKE ERIE COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

Author keywords

Bone marrow failure; Cysteamine; Cystinosis; Leukopenia

Indexed keywords

CYCLOSPORIN; CYSTINE; MERCAPTAMINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; BONE MARROW BIOPSY; BONE MARROW DEPRESSION; CASE REPORT; CLINICAL FEATURE; CYSTINOSIS; DISEASE ASSOCIATION; HEMODIALYSIS; HISTIOCYTE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DISEASE; KIDNEY FIBROSIS; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LABORATORY TEST; MALE; PANCYTOPENIA; PRIORITY JOURNAL;

ADULT; ANTILYMPHOCYTE SERUM; BONE MARROW; COMBINED MODALITY THERAPY; CRYSTALLIZATION; CYSTEAMINE; CYSTINE; CYSTINOSIS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MACROPHAGES; MALE; PANCYTOPENIA; POSTOPERATIVE COMPLICATIONS; T-LYMPHOCYTES;

EID: 46049109128     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000134222     Document Type: Article

References (26)

1. Nesterova G, Gahl W: Nephropathic cystinosis: late complications of a multisystemic disease. Pediatr Nephrol 2007, E-pub ahead of print.
2. Gahl WA, Thoene JG, Schneider JA: Cystinosis. N Engl J Med 2002;347:111-121.
3. Anikster Y, Shotelersuk V, Gahl WA: CTNS mutations in patients with cystinosis. Hum Mutat 1999;14:454-458.
4. Gahl WA, Balog JZ, Kleta R: Nephropathic cystinosis in adults: natural history and effects of oral cysteamine therapy. Ann Intern Med 2007;147:242-250.
5. Kleta R, Gahl WA: Pharmacological treatment of nephropathic cystinosis with cysteamine. Expert Opin Pharmacother 2004;5:2255-2262.
6. Kleta R, Gahl WA: Cystinosis: antibodies and healthy bodies. J Am Soc Nephrol 2002;13:2189-2191.
7. Dohil R, Fidler M, Barshop BA, Gangoiti J, Deutsch R, Martin M, Schneider JA: Understanding intestinal cysteamine bitartrate absorption. J Pediatr 2006;148:764-769.
8. Busuttil DP, Liu Yin JA: The bone marrow in hereditary cystinosis. Br J Haematol 2000;111:385.
9. Gebrail F, Knapp M, Perotta G, Cualing H: Crystalline histiocytosis in hereditary cysinosis. Arch Pathol Lab Med 2002;126:1135.
10. Quinn JP, Royston D, Murphy PT: Bone marrow findings in hereditary cystinosis with renal failure. Am J Hematol 2004;76:79.
11. Bigley V, Bhartia S, Wood A: Nephropathic cystinosis with bone marrow involvement. Br J Haematol 2007;136:180.
12. Broyer M, Tete MJ, Gubler MC: Late symptoms in infantile cystinosis. Pediatr Nephrol 1987;1:519-524.
13. Haase M, Morgera S, Bamberg C, Halle H, Martini S, Dragun D, Neumayer HH, Budde K: Successful pregnancies in dialysis patients including those suffering from cystinosis and familial Mediterranean fever. J Nephrol 2006;19:677-681.
14. Olcay L, Erdemli E, Kesimer M, Buyukasik Y, Okur H, Kalkanoglu HS, Coskun T, Altay C: High cystine in platelets from patients with nephropathic cystinosis: a chemical, ultrastructural, and functional evaluation. J Clin Pathol 2005;58:939-945.
15. Levtchenko E, de Graaf-Hess A, Wilmer M, van den Heuvel L, Monnens L, Blom H: Altered status of glutathione and its metabolites in cystinotic cells. Nephrol Dial Transplant 2005;20:1828-1832.
16. da Silva VA, Zurbrugg RP, Lavanchy P, Blumberg A, Suter H, Wyss SR, Luthy CM, Oetliker OH: Long-term treatment of infantile nephropathic cystinosis with cysteamine. N Engl J Med 1985;313:1460-1463.
17. Markello TC, Bernardini IM, Gahl WA: Improved renal function in children with cystinosis treated with cysteamine. N Engl J Med 1993;328:1157-1162.
18. Broyer M, Tete MJ, Guest G, Bertheleme JP, Labrousse F, Poisson M: Clinical polymorphism of cystinosis encephalopathy. Results of treatment with cysteamine. J Inherit Metab Dis 1996;19:65-75.
19. Gahl WA, Charnas L, Markello TC, Bernardini I, Ishak KG, Dalakas MC: Parenchymal organ cystine depletion with long-term cysteamine therapy. Biochem Med Metab Biol 1992;48:275-285.
20. Kimonis VE, Troendle J, Rose SR, Yang ML, Markello TC, Gahl WA: Effects of early cysteamine therapy on thyroid function and growth in nephropathic cystinosis. J Clin Endocrinol Metab 1995;80:3257-3261.
21. Sonies BC, Almajid P, Kleta R, Bernardini I, Gahl WA: Swallowing dysfunction in 101 patients with nephropathic cystinosis: benefit of long-term cysteamine therapy. Medicine (Baltimore) 2005;84:137-146.
22. Ueda M, O'Brien K, Rosing DR, Ling A, Kleta R, McAreavey D, Bernardini I, Gahl WA: Coronary artery and other vascular calcifications in patients with cystinosis after kidney transplantation. Clin J Am Soc Nephrol 2006;1:555-562.
23. Tsilou ET, Rubin BI, Reed G, Caruso RC, Iwata F, Balog J, Gahl WA, Kaiser-Kupfer MI: Nephropathic cystinosis: posterior segment manifestations and effects of cysteamine therapy. Ophthalmology 2006;113:1002-1009.
24. Kleta R, Bernardini I, Ueda M, Varade WS, Phornphutkul C, Krasnewich D, Gahl WA: Long-term follow-up of well-treated nephropathic cystinosis patients. J Pediatr 2004;145:555-560.
25. Tsilou ET, Thompson D, Lindblad AS, Reed GF, Rubin B, Gahl W, Thoene J, Del Monte M, Schneider JA, Granet DB, Kaiser-Kupfer MI: A multicentre randomised double masked clinical trial of a new formulation of topical cysteamine for the treatment of corneal cystine crystals in cystinosis. Br J Ophthalmol 2003;87:28-31.
26. Gahl WA, Kuehl EM, Iwata F, Lindblad A, Kaiser-Kupfer MI: Corneal crystals in nephropathic cystinosis: natural history and treatment with cysteamine eyedrops. Mol Genet Metab 2000;71:100-120.